XEEClyn-200-SR
Description_Effects
XEEClyn-200-SR is a sustained-release formulation containing Acebrophylline 200mg, a medicine widely used for the treatment of respiratory conditions such as asthma, chronic bronchitis, and chronic obstructive pulmonary disease (COPD). Acebrophylline is a dual-action agent that combines bronchodilator and mucolytic properties, offering relief by addressing both airway constriction and mucus build-up. The bronchodilator action works by relaxing the smooth muscles in the airways, allowing the air passages in the lungs to widen and facilitating easier breathing. Simultaneously, its mucolytic effect breaks down and thins the thick mucus secretions in the respiratory tract, helping to clear the airways and reduce coughing. XEEClyn-200-SR is formulated as a sustained-release tablet, which ensures a consistent release of medication throughout the day, improving symptom control and reducing the need for frequent dosing. This makes it particularly useful for managing chronic respiratory conditions that require long-term maintenance therapy. Patients using XEEClyn-200-SR often experience reduced shortness of breath, easier mucus clearance, and improved lung function over time. It should be taken exactly as prescribed by a doctor and is usually taken with food to minimize the risk of stomach upset. Regular use helps in preventing exacerbations and maintaining better respiratory health.
